The Rx Newsletter (HOC)

Rx Communications celebrates 25 years of transforming clinical data into meaningful, impactful communication. This milestone reflects our commitment to clarity, evidence, and innovation as we help shape the future of MedComms.

Learn how compassionate communication can reshape lung cancer awareness, challenge stigma, and foster understanding in this month’s Health Outcomes Communicator.

Understand the latest in breast cancer awareness, BRCA treatment timing, and oncology innovation — and quiz yourself on cancer facts.

See how awareness, innovation, and practical action can strengthen brain health, research, and patient-centred care.

Explore how MedComms shapes crisis response through clear, timely communication—plus updates in oncology, neurology, and clinical trial insights.

How pharma is rethinking patient care, plain language, and AI—plus the latest in Alzheimer’s, cancer, and aging diagnostics.

Skin cancer is preventable—so why do tanning beds still thrive? Explore the behaviours, strategies, and breakthroughs shaping awareness this May.

Find out how World Health Day 2025 highlights maternal drug safety, newborn health, and the crucial role of MedComms in driving change.

HOC returns with fresh insights on oncology, Daffodil Day, cancer research, and the latest medical advances shaping patient outcomes.

Shining a light on Rare Disease Day 2024 and the extraordinary resilience of those living with rare and overlooked conditions.

Highlighting diabetes awareness, care access, and groundbreaking innovations in Alzheimer’s, gene therapy, and preventative treatments in global health.

Get the latest from Rx Communications — Alzheimer’s updates, Medicare insights, conference tips, and strategies for year-end success.

Exploring how AI like ChatGPT is transforming healthcare—from diagnostics to patient notes—and reshaping trust, ethics, and communication.

Uncover how GLP-1 treatments, surgical options, and preventive measures are shifting both the science and stigma of obesity.

Explore the promise and perils of genetic editing, from CRISPR breakthroughs to ethical debates on access, equity, and reproductive medicine.